These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
95 related articles for article (PubMed ID: 10213754)
1. Medical student electives and infectious diseases. Zidovudine alone is not recommended prophylaxis. Meadway J BMJ; 1999 Apr; 318(7191):1145-6. PubMed ID: 10213754 [No Abstract] [Full Text] [Related]
2. Chemoprophylaxis after occupational exposure to human immunodeficiency virus in forensic autopsy. Kibayashi K; NG'walali PM; Tsunenari S Nihon Hoigaku Zasshi; 1998 Apr; 52(2):163-4. PubMed ID: 9711070 [No Abstract] [Full Text] [Related]
3. Failure to develop HIV infection after receipt of HIV-contaminated blood and postexposure prophylaxis. Katzenstein TL; Dickmeiss E; Aladdin H; Hede A; Nielsen C; Nielsen H; Jørgensen LB; Gerstoft J Ann Intern Med; 2000 Jul; 133(1):31-4. PubMed ID: 10877737 [No Abstract] [Full Text] [Related]
4. Maintenance antiretroviral therapies in HIV-infected subjects with undetectable plasma HIV RNA after triple-drug therapy. AIDS Clinical Trials Group Study 343 Team. Havlir DV; Marschner IC; Hirsch MS; Collier AC; Tebas P; Bassett RL; Ioannidis JP; Holohan MK; Leavitt R; Boone G; Richman DD N Engl J Med; 1998 Oct; 339(18):1261-8. PubMed ID: 9791141 [TBL] [Abstract][Full Text] [Related]
5. Drug shows potency against HIV. Dent Today; 1996 May; 15(5):22, 26. PubMed ID: 9567867 [No Abstract] [Full Text] [Related]
6. A randomized trial of three maintenance regimens given after three months of induction therapy with zidovudine, lamivudine, and indinavir in previously untreated HIV-1-infected patients. Trilège (Agence Nationale de Recherches sur le SIDA 072) Study Team. Pialoux G; Raffi F; Brun-Vezinet F; Meiffrédy V; Flandre P; Gastaut JA; Dellamonica P; Yeni P; Delfraissy JF; Aboulker JP N Engl J Med; 1998 Oct; 339(18):1269-76. PubMed ID: 9791142 [TBL] [Abstract][Full Text] [Related]
7. HIV trial stopped early after good results. Boulton A BMJ; 1997 Mar; 314(7082):699. PubMed ID: 9116542 [No Abstract] [Full Text] [Related]
8. HIV postexposure prophylaxis: new recommendations. Patrick DM CMAJ; 1997 Jan; 156(2):233-4. PubMed ID: 9012728 [No Abstract] [Full Text] [Related]
9. A controlled trial of two nucleoside analogues plus indinavir in persons with human immunodeficiency virus infection and CD4 cell counts of 200 per cubic millimeter or less. AIDS Clinical Trials Group 320 Study Team. Hammer SM; Squires KE; Hughes MD; Grimes JM; Demeter LM; Currier JS; Eron JJ; Feinberg JE; Balfour HH; Deyton LR; Chodakewitz JA; Fischl MA N Engl J Med; 1997 Sep; 337(11):725-33. PubMed ID: 9287227 [TBL] [Abstract][Full Text] [Related]
10. Treatment with indinavir, zidovudine, and lamivudine in adults with human immunodeficiency virus infection and prior antiretroviral therapy. Gulick RM; Mellors JW; Havlir D; Eron JJ; Gonzalez C; McMahon D; Richman DD; Valentine FT; Jonas L; Meibohm A; Emini EA; Chodakewitz JA N Engl J Med; 1997 Sep; 337(11):734-9. PubMed ID: 9287228 [TBL] [Abstract][Full Text] [Related]
11. A randomized, controlled trial of indinavir, zidovudine, and lamivudine in adults with advanced human immunodeficiency virus type 1 infection and prior antiretroviral therapy. Hirsch M; Steigbigel R; Staszewski S; Mellors J; Scerpella E; Hirschel B; Lange J; Squires K; Rawlins S; Meibohm A; Leavitt R J Infect Dis; 1999 Sep; 180(3):659-65. PubMed ID: 10438352 [TBL] [Abstract][Full Text] [Related]
12. Study confirms that protease inhibitor cocktail can delay HIV disease progression and death. Randall P NIAID AIDS Agenda; 1997 Mar; ():1-2. PubMed ID: 11364170 [TBL] [Abstract][Full Text] [Related]
14. Double protease inhibitor regimens with amprenavir show promise. AIDS Patient Care STDS; 1998 Apr; 12(4):317-8. PubMed ID: 11361962 [No Abstract] [Full Text] [Related]
15. Report updates recommendations for health workers exposed to HIV. Am J Health Syst Pharm; 1998 Sep; 55(17):1755. PubMed ID: 9867409 [No Abstract] [Full Text] [Related]
16. HIV-1 RNA detectable with ultrasensitive quantitative polymerase chain reaction in plasma but not in cerebrospinal fluid during combination treatment with zidovudine, lamivudine and indinavir. Gisslén M; Norkrans G; Svennerholm B; Hagberg L AIDS; 1998 Jan; 12(1):114-6. PubMed ID: 9456264 [No Abstract] [Full Text] [Related]
17. Needle-stick injuries and HIV infection: a surgeon's personal experience and review of postexposure prophylaxis. St. Paul's Ocular AIDS Group. Hurwitz JJ; Fine N; Rachlis AR Can J Ophthalmol; 1999 Jun; 34(4):195-203. PubMed ID: 10396655 [No Abstract] [Full Text] [Related]
18. Pharmacological basis for concentration-controlled therapy with zidovudine, lamivudine, and indinavir. Kakuda TN; Page LM; Anderson PL; Henry K; Schacker TW; Rhame FS; Acosta EP; Brundage RC; Fletcher CV Antimicrob Agents Chemother; 2001 Jan; 45(1):236-42. PubMed ID: 11120972 [TBL] [Abstract][Full Text] [Related]
19. Paediatric AIDS--is now not the right time to act? Matchaba PT; Chapanduka ZC S Afr Med J; 1997 Oct; 87(10):1343-5. PubMed ID: 9472245 [No Abstract] [Full Text] [Related]
20. Adherence to antiretroviral therapy and outcomes in HIV-infected patients enrolled in an induction/maintenance randomized trial. Flandre P; Peytavin G; Meiffredy V; Saidi Y; Descamps D; Delagnes M; Brun-Vézinet F; Raffi F; Antivir Ther; 2002 Jun; 7(2):113-21. PubMed ID: 12212923 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]